- $94.82m
- $97.70m
- 32
- 32
- 47
- 30
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.025 | 0.64 | 0.564 | 0.12 |
Net Total Receivables | — | 0 | 0 | 0 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 0.025 | 1.1 | 1.47 | 0.209 |
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 0.145 | 231 | 33.2 | 33.2 |
Payable / Accrued | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Current Liabilities | 0.122 | 1.14 | 3.71 | 4.69 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 0.122 | 19.4 | 13.9 | 16.4 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 0.023 | 212 | 19.2 | 16.8 |
Total Liabilities & Shareholders' Equity | 0.145 | 231 | 33.2 | 33.2 |
Total Common Shares Outstanding |